Imaging for Response Assessment in Radiation Oncology: Current and Emerging Techniques

Overview

Journal Hematol Oncol Clin North Am

Specialties Hematology
Oncology

Date 2019 Nov 20

PMID 31739950

Citations 6

Authors

Sonja Stieb

Kendall Kiser

Lisanne van Dijk

Nadia Roxanne Livingstone

Hesham Elhalawani

Baher Elgohari

Brigid McDonald

Juan Ventura

Abdallah Sherif Radwan Mohamed

Clifton David Fuller

Affiliations

Soon will be listed here.

Abstract

Imaging in radiation oncology is essential for the evaluation of treatment response in tumors and organs at risk. This influences further treatment decisions and could possibly be used to adapt therapy. This review article focuses on the currently used imaging modalities for response assessment in radiation oncology and gives an overview of new and promising techniques within this field.

Citing Articles

Coupling Lipid Labeling and Click Chemistry Enables Isolation of Extracellular Vesicles for Noninvasive Detection of Oncogenic Gene Alterations.

Sun N, Tran B, Peng Z, Wang J, Zhang C, Yang P Adv Sci (Weinh). 2022; 9(14):e2105853.

PMID: 35486030 PMC: 9108594. DOI: 10.1002/advs.202105853.

Computed Tomography as a Characterization Tool for Engineered Scaffolds with Biomedical Applications.

Olaret E, Stancu I, Iovu H, Serafim A Materials (Basel). 2021; 14(22).

PMID: 34832165 PMC: 8619049. DOI: 10.3390/ma14226763.

Improving radiation physics, tumor visualisation, and treatment quantification in radiotherapy with spectral or dual-energy CT.

Kruis M J Appl Clin Med Phys. 2021; 23(1):e13468.

PMID: 34743405 PMC: 8803285. DOI: 10.1002/acm2.13468.

Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review.

Riva G, Imparato S, Savietto G, Pecorilla M, Iannalfi A, Barcellini A Br J Radiol. 2021; 94(1128):20210524.

PMID: 34520670 PMC: 8631012. DOI: 10.1259/bjr.20210524.

FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancer.

Elhalawani H, Cardenas C, Volpe S, Barua S, Stieb S, Rock C Clin Transl Radiat Oncol. 2021; 29:93-101.

PMID: 34195391 PMC: 8239739. DOI: 10.1016/j.ctro.2021.05.011.

References

Abramyuk A, Hietschold V, Appold S, von Kummer R, Abolmaali N . Radiochemotherapy-induced changes of tumour vascularity and blood supply estimated by dynamic contrast-enhanced CT and fractal analysis in malignant head and neck tumours. Br J Radiol. 2014; 88(1045):20140412. PMC: 4277378. DOI: 10.1259/bjr.20140412. View

Petit S, van Elmpt W, Oberije C, Vegt E, Dingemans A, Lambin P . [¹⁸F]fluorodeoxyglucose uptake patterns in lung before radiotherapy identify areas more susceptible to radiation-induced lung toxicity in non-small-cell lung cancer patients. Int J Radiat Oncol Biol Phys. 2010; 81(3):698-705. DOI: 10.1016/j.ijrobp.2010.06.016. View

Wu H, Chen X, Yang X, Tao Y, Xia Y, Deng X . Early Prediction of Acute Xerostomia During Radiation Therapy for Head and Neck Cancer Based on Texture Analysis of Daily CT. Int J Radiat Oncol Biol Phys. 2018; 102(4):1308-1318. DOI: 10.1016/j.ijrobp.2018.04.059. View

Lombardi M, Cascone T, Guenzi E, Stecco A, Buemi F, Krengli M . Predictive value of pre-treatment apparent diffusion coefficient (ADC) in radio-chemiotherapy treated head and neck squamous cell carcinoma. Radiol Med. 2017; 122(5):345-352. DOI: 10.1007/s11547-017-0733-y. View

Lapointe A, Bahig H, Blais D, Bouchard H, Filion E, Carrier J . Assessing lung function using contrast-enhanced dual-energy computed tomography for potential applications in radiation therapy. Med Phys. 2017; 44(10):5260-5269. DOI: 10.1002/mp.12475. View

Avanzo M, Stancanello J, El Naqa I . Beyond imaging: The promise of radiomics. Phys Med. 2017; 38:122-139. DOI: 10.1016/j.ejmp.2017.05.071. View

OConnor J, Tofts P, Miles K, Parkes L, Thompson G, Jackson A . Dynamic contrast-enhanced imaging techniques: CT and MRI. Br J Radiol. 2012; 84 Spec No 2:S112-20. PMC: 3473907. DOI: 10.1259/bjr/55166688. View

Yao M, Graham M, Smith R, Dornfeld K, Skwarchuk M, Hoffman H . Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report. Int J Radiat Oncol Biol Phys. 2004; 60(5):1410-8. DOI: 10.1016/j.ijrobp.2004.05.058. View

Zyromska A, Malkowski B, Wisniewski T, Majewska K, Reszke J, Makarewicz R . O-HO PET/CT as a tool for the quantitative assessment of early post-radiotherapy changes of heart perfusion in breast carcinoma patients. Br J Radiol. 2018; 91(1088):20170653. PMC: 6209477. DOI: 10.1259/bjr.20170653. View

10.

Cha J, Kim S, Kim H, Kim B, Kim Y, Lee J . Differentiation of tumor progression from pseudoprogression in patients with posttreatment glioblastoma using multiparametric histogram analysis. AJNR Am J Neuroradiol. 2014; 35(7):1309-17. PMC: 7966603. DOI: 10.3174/ajnr.A3876. View

11.

Shukla-Dave A, Obuchowski N, Chenevert T, Jambawalikar S, Schwartz L, Malyarenko D . Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials. J Magn Reson Imaging. 2018; 49(7):e101-e121. PMC: 6526078. DOI: 10.1002/jmri.26518. View

12.

Abdollahi H, Mahdavi S, Shiri I, Mofid B, Bakhshandeh M, Rahmani K . Magnetic resonance imaging radiomic feature analysis of radiation-induced femoral head changes in prostate cancer radiotherapy. J Cancer Res Ther. 2019; 15(Supplement):S11-S19. DOI: 10.4103/jcrt.JCRT_172_18. View

13.

van Dijk L, Brouwer C, van der Laan H, Burgerhof J, Langendijk J, Steenbakkers R . Geometric Image Biomarker Changes of the Parotid Gland Are Associated With Late Xerostomia. Int J Radiat Oncol Biol Phys. 2017; 99(5):1101-1110. DOI: 10.1016/j.ijrobp.2017.08.003. View

14.

Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2008; 45(2):228-47. DOI: 10.1016/j.ejca.2008.10.026. View

15.

Kim S, Loevner L, Quon H, Sherman E, Weinstein G, Kilger A . Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res. 2009; 15(3):986-94. PMC: 2673914. DOI: 10.1158/1078-0432.CCR-08-1287. View

16.

Klein Nulent T, Valstar M, de Keizer B, Willems S, Smit L, Al-Mamgani A . Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018; 125(5):478-486. DOI: 10.1016/j.oooo.2018.01.011. View

17.

Okada H, Weller M, Huang R, Finocchiaro G, Gilbert M, Wick W . Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. Lancet Oncol. 2015; 16(15):e534-e542. PMC: 4638131. DOI: 10.1016/S1470-2045(15)00088-1. View

18.

Young H, Baum R, Cremerius U, Herholz K, Hoekstra O, Lammertsma A . Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer. 2000; 35(13):1773-82. DOI: 10.1016/s0959-8049(99)00229-4. View

19.

Stieb S, Elgohari B, Fuller C . Repetitive MRI of organs at risk in head and neck cancer patients undergoing radiotherapy. Clin Transl Radiat Oncol. 2019; 18:131-139. PMC: 6630152. DOI: 10.1016/j.ctro.2019.04.014. View

20.

Buxton R . The physics of functional magnetic resonance imaging (fMRI). Rep Prog Phys. 2013; 76(9):096601. PMC: 4376284. DOI: 10.1088/0034-4885/76/9/096601. View